Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You’re missing the fact that all biotech is crapping the bed.
Day 60 is Tuesday
22 million shares traded in 2021
Again, you are wrong. The drug actually looks even more appealing now, hence why they changed the endpoint to a significantly more difficult endpoint to meet. The data is blinded so they don’t know what drug is working but they can clearly see a specific cohort in the study is grossly outperforming the other cohort. Remdesivir did the opposite btw. They moved to an easier endpoint before the trial was complete in fear of not meeting it.
Not horrible news. SOC has drastically improved in the past couple months. The goal here is to justify EUA ASAP.
PI I think you are missing the whale money movement. It’s in the form of options here. Last week whale money loaded up on a crap ton of calls
Great question. Here is my take. For them to have changed their estimates from 515 to 511, they must already be quite close to 402 events. Any new “event” that occurs today or this week will have received the original lenz dose as far back as 28 days ago. Therefor it is possible that they could hit 402 events this week and at the same time enroll 511 people this week. The study will most likely have more than 402 events once it is all said and done
55 people out of how many that were given the vaccine? That 55 is probably less than .5% of the population that has been given the vaccine
And if did not start this weekend then we will get a PR at 402 events before we get a PR on enrollment completion IMO
I’m pretty sure the 28 day count has already started. They hit 257 events at 300 (85%). They are at 475 enrollments aka 403 events. The 28 day clock started this past weekend IMO
I know what you mean. HGEN just can’t seem to catch a break. Yahoo Finance gives HGEN a beta of -1 so hopefully it can ignore all the volatility and take off
So what if he gets better and recovers 100%? Does he hop back on the board? Does another 8k get filed? Cmon man
Lol! Cmon man that’s ridiculous. He is not resigning due to Covid. A company that is making a drug for Covid19 to save lives has a board member step down because he has Covid. Please stop
I refuse to believe they are barely over 450. My guess is between 470-480. Anything lower means the doctors are being threatened lol. Unfreaking believable
Man that’s F’ng slow. How is that possible?
Has anyone emailed Richard lately on enrollment update?
Agreed. We should be done by now honestly. Especially since there is a site in Atlanta and Dallas. Big opportunity for diversity in enrollments in those 2 cities
So are we just not going to get anymore enrollment updates until Jan 11th?
Nope. You are spot on
Profit taking that is all that is happening hear until year ends
You disappeared
Lol where did you go Fress??? I thought believed in this company
Probably EUA has not yet officially been granted but currently being reviewed
Wowwwwwww.
Facebook Granny-“Thats not how this works... That’s not how any of this works”
Poor Ohms they try so so so hard to attacked Humanigen lol.
That literally makes ZERO sense.... lol!!
Did we uplist to nasdaq yet?
Lol wtf man
It never stops. Humanigen does not exist anywhere but here.
Pretty nice gain on hundreds of millions of dollars
Thanks!
You never know though which sucks
Don’t forget about the shares unlocking in December that may get dumped. Hopefully not but I have seen it on other plays time and time again
They can though they just choose not to.
Vaccines Vaccines Vaccines Vaccines Vaccines, Lily Lily Lily, Testing Testing Testing, Regeneron, Vaccines Vaccines Vaccines
Len... Lending PPE PPE PPE
Not to mention we will have to worry about EUA/FDA news from those vaccine companies later this month or year.
Call me crazy but I think lenzi is operating at 98% efficiency in the P3 trial!! I showed the math in an earlier post.
Hey can you check my math on the post I sent to neo?
Okay Neo here we go.
Here is what we know
- Initial trial design n=300 to generate 257 event
- 257=“recovery” in required time frame (28 days)
- Lenzilumab is tracking at an HR=1.37
- 37% more recoveries observed on average.
___________________________________
My formula:
c= events from the control arm (SOC)
t= events from the treatment arm (lenz)
-Lenz has 37% more recoveries observed on average
1.37c = t
1.37c + c = 257 events
2.37c = 257
2.37c/2.37 = 257/2.37
c = 108 events on control arm through 28 days
108/150= 72% success rate for control arm
through 28 days
__________________________________
1.37c = t
1.37(108) = t
147 = t events on treatment side
147= 98% success rate for control arm
Lenz is trending at a 98% success rate
WTF... this looks like the cure if my math is right